Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Discovery and Validation of a Compound to Target Ewing’s Sarcoma

Pharmaceutics(2021)10.3390/pharmaceutics13101553Source: DataRank Database

Discovery and Validation of a Compound to Target Ewing’s Sarcoma is a research paper published in Pharmaceutics (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

uniprot nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.65)OA: goldTopics (24)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Fahad Y. Sabei ORCID,W. Vogel ORCID,Mohamad Nazari,Katelyn S. Nicholson ORCID,Philip R. Gafken ORCID

Live enrichment

PubMed:34683845 PMC:PMC8538197 OpenAlex:https://openalex.org/W3204668464

Oregon Health and Science University

Grant: N/A

National Institutes of Health

Grant: R01CA237569

National Institutes of Health

Grant: R37CA234006

National Institutes of Health

Grant: P30CA015704

FWCI

0.65

Citation Percentile

0.7%

Citation Trend

2022

2023

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4923/13/10/1553/pdf?version=1632636880

publisherhttps://www.mdpi.com/1999-4923/13/10/1553/pdf?version=1632636880

publisherhttps://www.mdpi.com/1999-4923/13/10/1553/pdf

journalhttps://doi.org/10.3390/pharmaceutics13101553

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34683845

Fields of Study

Sarcoma Diagnosis and TreatmentProtein Degradation and InhibitorsUbiquitin and proteasome pathways

Keywords

SarcomaPrometaphaseEwing's sarcomaCancer researchIn vivoMedicineCancerCytotoxic T cellSoft tissue sarcomaOncologyPathologyBiologyInternal medicineIn vitroCell cycleHigh-throughput screeningChemotherapyEwing’s sarcomadrug discoveryNanoparticle Drug DeliveryMl111

Sustainable Development Goals

SDG 0: Good health and well-being

Discovery and Validation of a Compound to Target Ewing’s Sarcoma

FAIR Checklist

Authors (10)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)